Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVOLUTION-ON: Angiomax vs Heparin in Cardiac Surgery on CPB
NCT00079586Phase 3Completed
- Sponsor
- The Medicines Company
- Start
- Apr 2004
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bivalirudin in coronary artery disease (CAD), heart valve disease, sponsored by The Medicines Company. Started Apr 2004; status: completed.
02
Drugs
bivalirudin
03
Conditions
coronary artery disease (CAD)heart valve disease
Beyond the preview
Go deeper on NCT00079586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079586.